Varma Bhavya, Ogunmoroti Oluseye, Ndumele Chiadi E, Kazzi Brigitte, Rodriquez Carla P, Osibogun Olatokunbo, Allison Matthew A, Bertoni Alain G, Michos Erin D
Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD, United States.
Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, United States.
Front Cardiovasc Med. 2023 Jan 13;9:1062460. doi: 10.3389/fcvm.2022.1062460. eCollection 2022.
Differences in sex hormone levels contribute to differences in cardiovascular disease (CVD) risk. Adipokines play a role in cardiometabolic pathways and have differing associations with CVD. Adipokine levels differ by sex; however, the association between sex hormone profiles and adipokines is not well established. We hypothesized that a more androgenic sex hormone profile would be associated with higher leptin and resistin and lower adiponectin levels among postmenopausal women, with the opposite associations in men.
We performed an analysis of 1,811 adults in the Multi-Ethnic Study of Atherosclerosis who had both sex hormones and adipokines measured an average of 2.6 years apart. Sex hormones [Testosterone (T), estradiol (E2), sex hormone binding globulin (SHBG), and dehydroepiandrosterone (DHEA)] were measured at exam 1; free T was estimated. Serum adipokines (leptin, resistin, adiponectin) were measured at exams 2 or 3. We used multivariable linear regression to examine the cross-sectional associations between sex hormones and adipokines.
The mean (SD) age was 63 (10) years, 48% were women; 59% non-White participants. For leptin, after adjusting for demographics only, higher free T and lower SHBG, were associated with higher leptin in women; this association was attenuated after further covariate adjustment. However in men, higher free T and lower SHBG were associated with greater leptin levels in fully adjusted models. For adiponectin, lower free T and higher SHBG were associated with greater adiponectin in both women and men after adjustment for CVD risk factors. For resistin, no significant association was found women, but an inverse association with total T and bioT was seen in men.
Overall, these results further suggest a more androgenic sex profile (higher free T and lower SHBG) is associated with a less favorable adipokine pattern. These findings may provide mechanistic insight into the interplay between sex hormones, adipokines, and CVD risk.
性激素水平的差异导致心血管疾病(CVD)风险存在差异。脂肪因子在心脏代谢途径中发挥作用,并且与CVD有不同的关联。脂肪因子水平存在性别差异;然而,性激素谱与脂肪因子之间的关联尚未完全明确。我们假设,在绝经后女性中,更具雄激素性的性激素谱与更高的瘦素和抵抗素水平以及更低的脂联素水平相关,而在男性中则存在相反的关联。
我们对动脉粥样硬化多民族研究中的1811名成年人进行了分析,这些人的性激素和脂肪因子平均间隔2.6年进行测量。在第一次检查时测量性激素[睾酮(T)、雌二醇(E2)、性激素结合球蛋白(SHBG)和脱氢表雄酮(DHEA)];估算游离睾酮。在第二次或第三次检查时测量血清脂肪因子(瘦素、抵抗素、脂联素)。我们使用多变量线性回归来研究性激素与脂肪因子之间的横断面关联。
平均(标准差)年龄为63(10)岁,48%为女性;59%为非白人参与者。对于瘦素,仅在调整人口统计学因素后,更高的游离睾酮和更低的SHBG与女性更高的瘦素相关;在进一步调整协变量后,这种关联减弱。然而,在男性中,在完全调整的模型中,更高的游离睾酮和更低的SHBG与更高的瘦素水平相关。对于脂联素,在调整心血管疾病风险因素后,更低的游离睾酮和更高的SHBG与女性和男性更高的脂联素相关。对于抵抗素,在女性中未发现显著关联,但在男性中观察到与总睾酮和生物活性睾酮呈负相关。
总体而言,这些结果进一步表明,更具雄激素性的性别谱(更高的游离睾酮和更低的SHBG)与不太有利的脂肪因子模式相关。这些发现可能为性激素、脂肪因子和心血管疾病风险之间的相互作用提供机制性见解。